L’étude Syde-CAR

How do you assess a patient too young to follow instructions? That’s the challenge our Program Director, Damien Eggenspieler, tackled on the ground at ICNMD

Can a single wearable platform derive meaningful clinical conclusions across 10+ neurological diseases? The evidence says yes.We’re presenting three new posters at EAN 2025, each

As the development of innovative therapies for ALS accelerates around the world, the need for objective and clinically meaningful measures of disease progression has never